- RBC Capital analyst Deane Dray raised the price target for Emerson Electric Co. EMR to $102 (an upside of 17%) from $96 while maintaining the Outperform rating on the shares.
- The analyst mentions that he braced for much noise in Outperform-rated Emerson's 3Q22 results given the portfolio moves of AspenTech closing on May 16, Therm-O-Disc divested on May 30, and pending InSinkErator divestment.
- Dray noted that adding to the commotion were the headwinds in China and ongoing chip shortages, together nicking $180 million in revenues, mainly in Automation.
- Dray expects to see more portfolio optimization moves at the November-29 NYC analyst meeting, if not sooner.
- Related: Emerson Electric Reports Q3 Sales Growth Of 7%, Raises FY22 EPS Guidance
- Mizuho Securities analyst Brett Linzey raised the price target on Emerson to $86 (a downside of 1.3%) from $85 while maintaining the Neutral rating on the shares. The analyst states that Q3 was in-line at the segment level.
- Citi analyst Andrew Kaplowitz raised the price target on Emerson to $99 from $96 while maintaining the Buy rating on the shares.
- The analyst states that despite some short-term sales impact brought on by supply chain issues and lockdowns in China, he still sees Emerson's "still robust" demand trends in underlying orders as an indication that a strong demand cycle is still in motion.
- Price Action: EMR shares are trading higher by 0.81% at $87.29 on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in